Avid Bioservices, Inc. (CDMO)
Feb 5, 2025 - CDMO was delisted (reason: acquired by GHO & Ampersand)
12.49
0.00 (0.00%)
Inactive · Last trade price on Feb 4, 2025
Avid Bioservices Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Avid Bioservices stock had an average target of $12.25, with a low estimate of $12 and a high estimate of $12.5.
Price Target: $12.25 (-1.92%)
Analyst Consensus: Hold
Price Target
Analyst Ratings
The average analyst rating for Avid Bioservices stock from 3 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.
Recommendation Trends
No data available
| Rating | Oct 2026 |
|---|---|
| Strong Buy | n/a |
| Buy | n/a |
| Hold | n/a |
| Sell | n/a |
| Strong Sell | n/a |
| Total | n/a |
Financial Forecast
Revenue This Year
166.37M
from 139.91M
Increased by 18.91%
Revenue Next Year
194.26M
from 166.37M
Increased by 16.76%
EPS This Year
-0.34
from -2.23
EPS Next Year
-0.06
from -0.34
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 172.3M | 206.0M | |||
| Avg | 166.4M | 194.3M | |||
| Low | 159.0M | 180.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 23.1% | 23.8% | |||
| Avg | 18.9% | 16.8% | |||
| Low | 13.6% | 8.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.26 | 0.12 | |
| Avg | -0.34 | -0.06 | |
| Low | -0.40 | -0.21 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |